These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 24098456)
1. 2,3,7,8-tetrachlorodibenzo-p-dioxin slows the progression of experimental cutaneous Leishmaniasis in susceptible BALB/c and SCID mice. DeKrey GK; Teagarden RE; Lenberg JL; Titus RG PLoS One; 2013; 8(10):e76259. PubMed ID: 24098456 [TBL] [Abstract][Full Text] [Related]
2. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) reduces Leishmania major burdens in C57BL/6 mice. Bowers OJ; Sommersted KB; Sowell RT; Boling GE; Hanneman WH; Titus RG; Dekrey GK Am J Trop Med Hyg; 2006 Oct; 75(4):749-52. PubMed ID: 17038706 [TBL] [Abstract][Full Text] [Related]
3. The growth and infectivity of Leishmania major is not altered by in vitro exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Sazhnev V; DeKrey GK BMC Res Notes; 2018 Sep; 11(1):642. PubMed ID: 30180875 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of amiodarone in treatment of cutaneous leishmaniasis caused by Leishmania major. Bemani E; Oryan A; Bahrami S Exp Parasitol; 2019 Oct; 205():107747. PubMed ID: 31442454 [TBL] [Abstract][Full Text] [Related]
5. Treatment with synthetic lipophilic tyrosyl ester controls Leishmania major infection by reducing parasite load in BALB/c mice. Sghaier RM; Aissa I; Attia H; Bali A; Leon Martinez PA; Mkannez G; Guerfali FZ; Gargouri Y; Laouini D Parasitology; 2016 Oct; 143(12):1615-21. PubMed ID: 27312247 [TBL] [Abstract][Full Text] [Related]
6. Effects of aging on resistance to Trichinella spiralis infection in rodents exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Luebke RW; Copeland CB; Andrews DL Toxicology; 1999 Aug; 136(1):15-26. PubMed ID: 10499847 [TBL] [Abstract][Full Text] [Related]
7. 2,3,7,8-Tetrachlorodibenzo-p-dioxin affects the number and function of murine splenic dendritic cells and their expression of accessory molecules. Vorderstrasse BA; Kerkvliet NI Toxicol Appl Pharmacol; 2001 Mar; 171(2):117-25. PubMed ID: 11222087 [TBL] [Abstract][Full Text] [Related]
8. Appraisal of a Leishmania major strain stably expressing mCherry fluorescent protein for both in vitro and in vivo studies of potential drugs and vaccine against cutaneous leishmaniasis. Calvo-Álvarez E; Guerrero NA; Alvarez-Velilla R; Prada CF; Requena JM; Punzón C; Llamas MÁ; Arévalo FJ; Rivas L; Fresno M; Pérez-Pertejo Y; Balaña-Fouce R; Reguera RM PLoS Negl Trop Dis; 2012; 6(11):e1927. PubMed ID: 23209866 [TBL] [Abstract][Full Text] [Related]
9. Topical treatment with hexadecylphosphocholine (Miltex) efficiently reduces parasite burden in experimental cutaneous leishmaniasis. Schmidt-Ott R; Klenner T; Overath P; Aebischer T Trans R Soc Trop Med Hyg; 1999; 93(1):85-90. PubMed ID: 10492799 [TBL] [Abstract][Full Text] [Related]
10. Leishmania tropica: suggestive evidences for the effect of infectious dose on pathogenicity and immunogenicity in an experimental model. Rostamian M; Jafari D; Abolghazi M; Farahani H; Niknam HM Parasitol Res; 2018 Sep; 117(9):2949-2956. PubMed ID: 29978420 [TBL] [Abstract][Full Text] [Related]
11. Colloidal, in vitro and in vivo anti-leishmanial properties of transfersomes containing paromomycin sulfate in susceptible BALB/c mice. Bavarsad N; Fazly Bazzaz BS; Khamesipour A; Jaafari MR Acta Trop; 2012 Oct; 124(1):33-41. PubMed ID: 22750480 [TBL] [Abstract][Full Text] [Related]
12. Leishmanicidal potentials of Sharifi F; Sharififar F; Pournamdari M; Ansari M; Tavakoli Oliaee R; Bamorovat M; Khosravi A; Keyhani AR; Salarkia E; Mortazaeizdeh A; Dabiri S; Khamesipour A; Sharifi I J Med Microbiol; 2021 Jun; 70(6):. PubMed ID: 34115583 [No Abstract] [Full Text] [Related]
13. Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice. Courret N; Lang T; Milon G; Antoine JC Int J Parasitol; 2003 Oct; 33(12):1373-83. PubMed ID: 14527520 [TBL] [Abstract][Full Text] [Related]
14. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice. Tonui WK; Mbati PA; Anjili CO; Orago AS; Turco SJ; Githure JI; Koech DK East Afr Med J; 2001 Feb; 78(2):90-2. PubMed ID: 11682953 [TBL] [Abstract][Full Text] [Related]
15. Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of Schleicher U; Liese J; Justies N; Mischke T; Haeberlein S; Sebald H; Kalinke U; Weiss S; Bogdan C Front Immunol; 2018; 9():79. PubMed ID: 29459858 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of miltefosine treatment in Leishmania amazonensis-infected BALB/c mice. Godinho JL; Simas-Rodrigues C; Silva R; Ürmenyi TP; de Souza W; Rodrigues JC Int J Antimicrob Agents; 2012 Apr; 39(4):326-31. PubMed ID: 22226653 [TBL] [Abstract][Full Text] [Related]
17. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633 [TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan. Halliday A; Bates PA; Chance ML; Taylor MJ Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391 [TBL] [Abstract][Full Text] [Related]
19. The immunotoxic effects of dual exposure to PCP and TCDD. Chen HM; Lee YH; Chen RJ; Chiu HW; Wang BJ; Wang YJ Chem Biol Interact; 2013 Nov; 206(2):166-74. PubMed ID: 24051191 [TBL] [Abstract][Full Text] [Related]
20. Response of scid mice to establishment of Leishmania major infection. Guy RA; Belosevic M Clin Exp Immunol; 1995 Jun; 100(3):440-5. PubMed ID: 7774053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]